1
0
0
News
2019 Referenten - AIO Herbstkongresswww.aio-herbstkongress.de › Archiv
www.aio-herbstkongress.de
Dr. Claudia-Nanette Gann Merck Healthcare KGaA Darmstadt. Dr. Deniz Gencer Universitätsmedizin Mannheim
Netzwerk-Profile
LinkedIn: Claudia-Nanette Dr. Gann | LinkedIn
Claudia-Nanette Dr. Ganns berufliches Profil anzeigen LinkedIn ist das weltweit ... of Janssen Cilag GmbH, Neuss, Germany,; Augusta Krankenanstalt Bochum.
Interessen
Docetaxel plus nintedanib versus docetaxel plus EM consultewww.em-consulte.com › article › docetaxel-plus-nin...
www.em-consulte.com
... MD, Igor Bondarenko, ProfMD, Meilin Liao, ProfMD, Claudia-Nanette Gann, MD, José Barrueco, PhD, Birgit Gaschler-Markefski, PhD, Silvia Novello, ProfMD.
Lancet Oncology, The - Vol n° 2 - EM consulte
www.em-consulte.com
Le site de référence en informations médicales et paramédicales - EM|consulte
Private Homepages
Docetaxel plus nintedanib versus docetaxel plus placebo in patients...
ikm.ku.dk
... and Maya Gottfried and Igor Bondarenko and Meilin Liao and Claudia-Nanette Gann and José Barrueco and Birgit Gaschler-Markefski and Silvia Novello and ...
Bücher
Claudia-Nanette Gann | XanEdu Customization Platform
www.academicpub.com
Author: Claudia-Nanette Gann. Results. DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for ...
Dokumente zum Namen
DSMM XI study: dose definition for intravenous cyclophosphamide in...
www.scienceopen.com
Authors: Martin Kropff, Peter Liebisch, Stefan Knop, Katja Weisel, Hannes Wand, Claudia-Nanette Gann, Wolfgang E. Berdel, Herrmann ...
Docetaxel plus nintedanib versus docetaxel plus placebo in patients...
tlo-reck-112309-20190018.elsevierreprint.com
... Meilin Liao Prof, Claudia-Nanette Gann MD, José Barrueco PhD, Birgit Gaschler-Markefski PhD, Silvia Novello Proffor the LUME-Lung 1 Study Group.
[PDF] Gann Study Group - Page List › e_gann-study-group_iYQCmwkfa
157.230.251.82
JULY 10TH, IGOR BONDARENKO MEILIN LIAO CLAUDIA NANETTE GANN JOSé BARRUECO BIRGIT GASCHLER MARKEFSKI SILVIA NOVELLO ...
Veröffentlichungen allgemein
[PDF] DSMM XI study: dose definition for intravenous COREcore.ac.uk › download › pdf
core.ac.uk
Katja Weisel & Hannes Wand & Claudia-Nanette Gann &. Wolfgang E. Berdel & Herrmann Einsele & on behalf of the Deutsche Studiengruppe Multiples.
Publications Authored by Claudia-Nanette Gann | PubFacts
www.pubfacts.com
Publications Authored by Claudia-Nanette Gann
DSMM XI study: dose definition for intravenous cyclophosphamide in...
link.springer.com
A clinical trial was initiated to evaluate the recommended dose of cyclophosphamide in combination with bortezomib and dexamethasone as induction treatment
Sonstiges
Claudia-Nanette Dr. Gann | LinkedIn
www.linkedin.com
View Claudia-Nanette Dr. Gann's professional profile on LinkedIn Division of Janssen Cilag GmbH, Neuss, Germany,; Augusta Krankenanstalt Bochum.
Multiple Myeloma: Gann, Claudia-Nanette - Expertscape.com
www.expertscape.com
Medical and scientific articles about Multiple Myeloma, written by Claudia-Nanette Gann
Referenzliste
www.horst-boehlke.de
Dr. Claudia Nanette Gann, Merck KGaA, Darmstadt Senior Medical Director & Global Medical Affairs Lead - Tepotinib & Lung Cancer Portfolio "Die Entwicklungen im Bereich der Leukämietherapie umfassen weit mehr als pharmakologische Ansätze.
*|MC:SUBJECT|* - SEOMseom.org › seom-informa
seom.org
... Igor Bondarenko, Meilin Liao, Claudia-Nanette Gann, José Barrueco, Birgit Gaschler-Markefski, Silvia Novello, for the LUME-Lung 1 Study Group.
Time since start of first-line therapy as a predictive clinical marker for ...
mdanderson.elsevierpure.com
Birgit Gaschler-Markefski, Patricia Sikken, John V. Heymach, Maya Gottfried, Anders Mellemgaard, Silvia Novello, Claudia Nanette Gann, José Barrueco, ... › ...
Afatinib versus cisplatin plus gemcitabine for first-line treatment of ...read.qxmd.com › read › afatinib-versus-cisplatin-plus-gemcitabine-for-first...
read.qxmd.com
FUNDING: Boehringer Ingelheim Meilin Liao, Claudia-Nanette Gann, José Barrueco, Birgit Gaschler-Markefski, Silvia Novello Lancet Oncology 2014, 15 (2): ...
Docetaxel plus nintedanib versus docetaxel plus Read by QxMDread.qxmd.com › read › docetaxel-plus-nintedanib-...
read.qxmd.com
... Joachim von Pawel, Maya Gottfried, Igor Bondarenko, Meilin Liao, Claudia-Nanette Gann, José Barrueco, Birgit Gaschler-Markefski, Silvia Novello.
Docetaxel plus nintedanib versus docetaxel plus placebo in patients...
research.regionh.dk
... and Meilin Liao and Claudia-Nanette Gann and José Barrueco and Birgit Gaschler-Markefski and Silvia Novello and {LUME-Lung 1 Study Group}",.
Response to 'Dai W et al. Am J Cancer Res 2015;5(10) - PubMedpubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
Authors. Claudia-Nanette Gann , Nassim Morsli , Xiaoxiang Chen , José Barrueco. Affiliations. 1 Boehringer Ingelheim GmbH Ingelheim, Germany.
Table 1 from Industry corner: perspectives and controversies - The ...www.semanticscholar.org › paper › figure
www.semanticscholar.org
Claudia-Nanette Gann, N. Morsli, R. Kaiser; Published 9 November 2016; Medicine, Political Science; Annals of oncology : official journal of the European ...
DSMM XI study: dose definition for intravenous cyclophosphamide in...
hal.archives-ouvertes.fr
Martin Kropff 1, * Peter Liebisch 2 Stefan Knop 3 Katja Weisel 4 Hannes Wand 5 Claudia-Nanette Gann 6 Wolfgang E. Berdel 1 Herrmann Einsele 3. Détails.
Docetaxel plus nintedanib versus docetaxel plus placebo in patients...
www.infona.pl
Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. autor. Claudia-Nanette Gann. Department of Medical Affairs, Boehringer Ingelheim ...
Nuevos datos avalan el beneficio en 2ª línea de nintenadib en...
gacetamedica.com
“Cuanto antes deje un paciente con adenocarcinoma de responder a la primera línea de tratamiento con quimioterapia, mayor es el beneficio que obtendrá...
La falta de previsión en la oferta MIR agrava el paro - PDF Descargar...
docplayer.es
Este es el principal resultado obtenido de un nuevo análisis del estudio en fase III Lume-Lung1, tal y como destaca Claudia-Nanette Gann, International Team ...
PRESIDENTIAL SYMPOSIUM SATURDAY, AUGUST 23, :30-08:15 - PDF Free...
docplayer.net
... INTERNA- TIONAL, RANDOMISED, DOUBLE-BLIND, PLACEBO-CON- TROLLED PHASE II STUDY Claudia-Nanette Gann, Martin Reck 2, Natasha Leighl 3, ...
Papers with the keyword M7824 | Read by QxMD
read.qxmd.com
... Schlichting, Christoph Helwig, Mary Ruisi, Hulin Jin, Juergen Scheuenpflug, Claudia-Nanette Gann, Zhen Su, Martin Reck, Everett E Vokes, Keith M Kerr.
Global Access and Impact: Closing the Gaps Schedule - Society for ...www.sitcancer.org › advocacy › workshops › sched...
www.sitcancer.org
· Panelists: Ute Dugan, MD, PhD – Parker Institute for Cancer Immunotherapy Claudia-Nanette Gann, MD – EMD Serono Frank Loeffler – Roche
Nuevos datos avalan el beneficio en 2ª línea de nintenadib en ...gacetamedica.com › Hemeroteca
gacetamedica.com
· ... en fase III Lume-Lung1, tal y como destaca Claudia-Nanette Gann, International Team Leader Medical Affairs Oncology de Boehringer.
Response to 'Dai W et al. Am J Cancer Res 2015;5(10): www.semanticscholar.org › paper › Response-to-'Da...
www.semanticscholar.org
Claudia-Nanette Gann, N. Morsli, +1 author J. Barrueco; Published 2016; Medicine; American journal of cancer research. We are writing as representatives of ...
Vision für Neroberg-Erlebnismulde: Mit Dach überm Kopf wetterfeste ...sensor-wiesbaden.de › vision-fuer-neroberg-erlebnismulde-mit-dach-ueber...
sensor-wiesbaden.de
· Und die Visionäre müssen sich durchsetzen. Meine Unterstützung haben sie. Mehr davon. Let's play! Claudia-Nanette Gann sagt:.
Verwandte Suchanfragen zu Claudia-Nanette Gann
| Juergen Scheuenpflug Christoph Helwig Peter Liebisch | Michael Schlichting Katja Weisel Martin Reck | Stefan Knop Birgit Gaschler-Markefski |
Personen Vorname "Claudia-Nanette" (2) Name "Gann" (728) |
sortiert nach Relevanz / Datum